BioCentury
ARTICLE | Clinical News

CBP501: Phase II started

December 15, 2008 8:00 AM UTC

The partners began an open-label, international Phase II trial to evaluate cisplatin and pemetrexed with or with intravenous CBP501 in 65 patients. Takeda has exclusive rights to the product outside o...